Your browser does not support JavaScript!



[2019/02/02] NYMU Bio-Navigator - Corporate Keynote Speech Invited ASUS Life to Present Their Experiences with Smart and Precision Medicine

GLORIA II invited HC Wu (in the center), the general manager of ASUS Life, to present the new opportunities that smart and precision medicine presents; he is with Monica Bey CEO of the Industry and Faculty Administration Center (left) and JC Hsieh, Vice President of Yang-Ming (right).


With society undeniably aging, various digital technologies have become part of the healthcare industry, which subsequently has given rise to a number of smart applications. Therefore, the key to being a future leader in healthcare relies on seizing the opportunities available from information technology in a sound way. In this context, National Yang-Ming University Business Center of Industry-Academia Liaison Serial Events of Bio-navigator -- Corporate Keynote Speech invited HC Wu, the general manager of ASUS Life, who is committed to developing smart medicine, to present the four hottest topics in this area on December 6, 2018. Hopefully, ASUS Life’s experience in promoting strategic policies in a domain such as this will enable faculty members and students dedicated to related R&D at National Yang-Ming University to strive towards a precision approach to medicine and identify mutual engagement opportunities in the healthcare industry as the best available targets.


As mentioned by HC Wu, the general manager of ASUS Life, he felt strong links with National Yang-Ming University. Hospital


To cope with the demand for digital transformation in the healthcare industry, ASUS began to engage in smart medicine in 2016 in association with Show Chwan Hospital. The aim was to launch ASUS Life via a joint venture that made the company an integrator responsible for fundamental software development, fundamental hardware development and the creation of advanced cloud data analytical systems. According to Wu, smart medicine not only helps build smart hospitals for commercial purposes, but also has significant impacts on precision medicine. In light of the recent digital wave associated with Virtual Assistants, Internet of Medical Things (IoMT), Big Data, and Artificial Intelligence (AI), ASUS Life is focusing on individualized precision medicine area that involves the active launching of one-of-a-kind products and services.


To handle the needs associated with care of the elderly in the near future, ASUS has collaborated with IBM Watson to introduce Zenbo, a smart robot for hospitals as the best realization of developing a Virtual Assistant for this type of environment. In terms of IoMT, in order to increase the opportunities for the innovative medical equipment industry to cooperate with hospitals, OmniCare, a smart medical equipment sharing platform, was founded by ASUS; this is able to serve as a unique ecology for IoMT. Wu believes that ASUS will act in a motherboard role and become responsible for the single standard to be used with medical equipment within hospitals; this would be via a single form of connection and equipment integration, which will speed up the mutual matching of and expansion of a wide range of systems.


Through the aggressive use of analysis of big data, the healthcare industry expects to find new optimal therapeutic approaches and novel causes of diseases. Wu stated that it is important develop precision medicine around robust data fundamentals, so ASUS has connected with various hospitals in order to form a network that helps hospitals be in contact with the international clinical trials industry. This occurs via PhenoFinder, a distributed medical data application platform. Furthermore, ASUS is cooperating with the National Health Insurance Administration’s plans to launch a health data bank. The next step is to integrate genomics and metabolomics data. With the opportunity available to collaborate with National Yang-Ming University and the abundant resources available to ASUS, the above should actually become a reality.


Finally, Wu emphasized that interdisciplinary cooperation (crossover) is vital. Applications are needed that outsmart the competitors at a similar technical level. Taking TAIWANIA 2 as an example, he expressly pointed out that the industry cannot thrive alone without working with university faculties in the future and that it is important to realize that the last mile to AI development is democratizing AI through the popularization of AI throughout the world.


The last remarks given by JC Hsieh Vice President anticipated that crossover between industry, university faculties, and medicine within the geographically related areas of Beitou and Guangdu is likely to be key to deploying smart medicine integration more effectively while promoting community services.